Severe pediatric asthma therapy: Dupilumab

Severe asthma is a rare disease affecting <5% of children with asthma. This group of patients account for about 50% of the costs of healthcare for children with asthma. Nowadays, several biological agents are available for pediatric severe asthma. One of these is dupilumab, a monoclonal antibody...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Giuliana Ferrante (Egilea), Laura Tenero (Egilea), Michele Piazza (Egilea), Giorgio Piacentini (Egilea)
Formatua: Liburua
Argitaratua: Frontiers Media S.A., 2022-11-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri